You have open access to this content

EMBO Molecular Medicine

Copyright © 2013 EMBO

All articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution License.   Articles accepted before this date were published under the agreement as stated in the final article.

Cover image for Vol. 5 Issue 5

Edited By: Stefanie Dimmeler (Chief Editor), Roberto Buccione and Céline Carret (EMBO Editors)

Impact Factor: 10.333

ISI Journal Citation Reports © Ranking: 2011: 6/112 (Medicine Research & Experimental)

Online ISSN: 1757-4684

Recently Published Issues

See all

News

More

Press release: A new animal model gives insights into mechanisms of Parkinson’s disease pathogenesis

EMBO Molecular Medicine - A new animal model gives insights into mechanisms of Parkinson’s disease pathogenesisScientists have developed a new model that reproduces the pattern of α-synuclein brain spreading in Parkinson's disease and provides important clues on the mechanisms underlying this pathological process.

Press release: Study identifies new approach to improving treatment for MS and other conditions

EMBO Molecular Medicine - Study identifies new approach to improving treatment for MS and other conditionsA UC Davis team led by Wenbin Deng have identified the mitochondrial protein TSPO as a potential therapeutic target for multiple sclerosis (MS) when mice that had symptoms of MS improved after being treated with the clinically available anti-anxiety drug etifoxine, which interacts with TSPO.

Most Accessed Articles

More

1.  Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC

2.  Autophagic control of cell ‘stemness’

3.  Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer

4.  Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain

5.  A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia

Editors' Choice

From Current Issue

Read Issue

SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis

EMBO Molecular Medicine - SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing ß-catenin biosynthesisYu Fu, Binlu Huang, Zhen Shi, Jiayu Han, Ying Wang, Jieqiong Huangfu and Wei Wu

From Early View

Access all Early View

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours

EMBO Molecular Medicine - Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumoursJiyoung Park, Thomas S. Morley and Philipp E. Scherer

Reviews Series

Review Series: Host-pathogen interactions

EMBO Molecular Medicine - Review Series: Host-pathogen interactionsHost-pathogen interactions remain a topic of substantial interest in fundamental and translational research, due to the persisting, high incidence of infectious diseases. This review series provides molecular insight from both host and pathogen perspectives.

Review Series: small RNAs

EMBO Molecular Medicine - Review Series: small RNAsDeregulated miRNAs are found intimately involved in human diseases, in cancer, hearing loss, but also neurodegenerative or cardiovascular diseases. This Review Series covers all those different aspects of small RNAs in diseases.

Review Series: Cardiovascular Diseases

EMBO Molecular Medicine - Review Series: Cardiovascular DiseasesCardiovascular diseases are still the leading cause of death worldwide. In this Review Series, the authors cover important emerging fields in cardiovascular research and translation.

SEARCH

SEARCH BY CITATION